Registration Is Now Open for Tribe Public's Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab's CEO
Registration Is Now Open for Tribe Public's Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab's CEO
Company to Provide a Detailed Overview of Mpox Including Commentary on the Rapid Spread and Methods for Control, Treatment, and Prevention
公司将提供关于Mpox的详细概述,包括对其快速传播和防控、治疗、预防方法的评论。
ATLANTA, GA, Aug. 21, 2024 (GLOBE NEWSWIRE) -- GeoVax Lab, Inc. (Nasdaq: GOVX) ("GeoVax Labs" or the "Company"), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that David Dodd, CEO of GeoVax Labs, will present at Tribe Public's Webinar Presentation and Q&A Event titled "Now Is Not the Time to Monkey(pox) Around." The Event is scheduled to begin at 8:00am PT / 11:00am ET on Friday, August 23, 2024. To register to join the complimentary event, please visit the Tribe Public LLC website at MonkeyPox.TribePublic.com.
亚特兰大,2024年8月21日(全球新闻社) - GeoVax Lab, Inc.(纳斯达克: GOVX)("GeoVax Labs" 或 "公司")是一家生物技术公司,正在开发用于对抗癌症和传染病的免疫疗法和疫苗,今天宣布GeoVax Labs 的首席执行官大卫·多德将在 Tribe Public 的 Webinar Presentation 和 Q&A 活动中发表题为“现在不是玩猴子痘的时候”的演讲。该活动定于2024年8月23日星期五上午8:00 Pt/11:00 Et开始。若要注册参加这个免费活动,请访问 Tribe Public LLC 的网站 MonkeyPox.TribePublic.com。
Once registered, participants may begin forwarding their questions for the CEO to Tribe Public at research@tribepublic.com or share their questions via the ZOOM chat feature during the event. Tribe Public's Managing Member, John F. Heerdink, Jr., will host the event and relay all questions to management.
注册后,参与者可以通过发送电子邮件至 research@tribepublic.com 或在活动期间通过ZOOm聊天功能分享问题给 Tribe Public。 Tribe Public 的执行成员约翰·F·希尔丁克 将主持这个活动并转达所有问题给管理层。
About GeoVax
关于GeoVax
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world's most threatening infectious diseases and therapies for solid tumor cancers. The company's lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin, in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: .
GeoVax Labs,Inc.是一家临床阶段的生物技术公司,为世界上最具威胁的传染病开发新型疫苗和固体肿瘤癌症的治疗方案。该公司的主要临床项目是GEO-CM04S1,这是一种下一代COVID-19疫苗,GeoVax最近获得了一个BARDA资助的合同,赞助一项10,000参与者的第20亿期临床试验,以评估GEO-CM04S1与经批准的COVID-19疫苗的疗效。此外,正在对GEO-CM04S1进行三个第2期临床试验评估,作为(1)免疫系统受损患者的主要疫苗,例如患血液肿瘤和其他当前授权的COVID-19疫苗不足的患者人群,(2)慢性淋巴细胞白血病(CLL)患者的诱导疫苗和(3)之前接种mRNA疫苗的健康患者更强、更持久的COVID-19增强剂。在肿瘤学中,主要临床项目正在多中心第1/2期临床试验中评估一种新型的肿瘤基因定向治疗Gedeptin,用于晚期头颈癌的治疗。GeoVax在支持其技术和产品的强大知识产权组合方面拥有强大的IP组合,全球拥有其技术和产品的权利。多个生命科学公司的领导团队在过去的几十年中推动了显着的价值创造。有关我们临床试验和其他更新的当前状态的更多信息,请访问我们的网站。
About Tribe Public LLC
关于 Tribe Public LLC
Tribe Public LLC is a San Francisco, CA based organization that hosts complimentary worldwide webinar & meeting events in the U.S. Tribe's complimentary events focus on issues that the Tribe members care about with an emphasis on hosting management teams from publicly traded companies from all sectors & financial organizations that are seeking to increase awareness of their products, progress and plans. Tribe members primarily include Family Offices, Portfolio Managers, Registered Investment Advisors, Accredited Investors, Sell Side Analysts, and members of media. Tribe Members are encouraged to express their interest in speakers they care about and want to learn from at the Tribe Public website via the Tribe's FREE "Wish List" process. Visit Tribe Public's Website to learn more:
Tribe Public LLC是位于加利福尼亚州旧金山的组织,主办免费的全球网络研讨会和会议。 Trib的免费活动主要关注部落成员关心的问题,并重点邀请来自所有板块和金融机构的管理团队,他们希望增加对其产品、进展和计划的认识。部落成员主要包括家族办公室、投资组合经理、注册投资顾问、高净值投资者、卖方分析师和媒体成员。 Trib鼓励部落成员通过Trib Public网站上的免费“心愿清单”流程表达他们对感兴趣的演讲者的兴趣和学习需求。访问Trib Public的网站了解更多信息:
Company Contact: | Investor Relations Contact: | Media Contact: | ||
info@geovax.com | austin.murtagh@precisionaq.com | sr@roberts-communications.com | ||
678-384-7220 | 212-698-8696 | 202-779-0929 |
公司联系人: | 投资者关系联系人: | 媒体联系人: | ||
info@geovax.com | austin.murtagh@precisionaq.com | sr@roberts-communications.com | ||
678-384-7220 | 212-698-8696 | 202-779-0929 |